
IndraLab
Statements
Hydroxychloroquine inhibits FASLG. 7 / 7
|
7
reach
"22 Observational studies in humans have also suggested a beneficial effect for the drug in reducing the risk of thrombosis XREF_BIBR - XREF_BIBR We showed, through ellipsometry and atomic force microscopic imaging of aPL immune complexes on planar phospholipid bilayers, that HCQ directly disrupts the formation of aPL immune complexes XREF_BIBR, XREF_BIBR and that this restores AnxA5 binding and crystallization on the planar bilayers, XREF_BIBR, XREF_BIBR Also, using quantitative immunoassays, we demonstrated that the drug also reduced aPL binding and restored AnxA5 expression on cultured BeWo trophoblasts."